PEN
Penumbra, Inc.
Medical Devices · Healthcare · United States
321.97
close · 2026-10-29
value
4
cheaper than peers4
quality
92
stronger fundamentals92
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 8.28× | 21 |
| forward P/E | 52.58× | 18 |
| price to sales | 8.39× | 13 |
| EV to EBITDA | 59.73× | 1 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| return on equity | 11.4% | 82 |
| operating margin | 10.5% | 78 |
| debt to equity | 13.9% | 73 |
| revenue growth | 14.9% | 65 |
4 of 4 measures available
Facts
| market cap | $13B |
| free cash flow | — |
| employees | 4,700 |
| first trade | 2015-09-18 |
| next earnings | not reported |
| fundamentals updated | 2026-07-31 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 4.52 | 0.36 | 2.32 | -0.05 |
| free cash flow | $174.9M | $147.3M | $82.1M | -$75.0M |
| net income | $177.7M | $14.0M | $91.0M | -$2.0M |
| revenue | $1.40B | $1.19B | $1.06B | $847.1M |
| unusual items | $0 | -$76.9M | -$18.2M | $0 |